Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06056583 · ClinicalTrials.gov registry record · Phase 4
Drug Excretion in Breast Milk
A Phase 4 study of Postpartum and Lactation, sponsored by University of Washington.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06056583: Recruiting Phase 4 study of Postpartum and Lactation, sponsored by University of Washington.
NCT06056583 is a Phase 4 study of Postpartum and Lactation that is actively recruiting participants, run by University of Washington. The registered enrollment target is 50 participants, below the 248-participant average among 16 other Postpartum trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06056583, a Phase 4 study of Postpartum and Lactation, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.
Primary Outcome
Cimetidine excretion into breast milk at three postpartum stages
Conditions Studied
Interventions
- DRUG Cimetidine 200 MG
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2028-09-30 |
| Phase | Phase 4 |
What NCT06056583 shows while recruiting
NCT06056583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 248-participant average among 16 other Postpartum trials with a reported enrollment target (80% lower).
The record links to 6 conditions, with Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Cimetidine 200 MG is the first listed.
NCT06056583 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06056583 about?
NCT06056583 is a clinical study titled "Drug Excretion in Breast Milk". This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.
What is the current status of trial NCT06056583?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2023-12-04. Estimated completion is 2028-09-30.
What conditions does trial NCT06056583 study?
This clinical trial studies the following conditions: Postpartum, Lactation, Drugs in Breast Milk, Mammary Drug Transporters, BCRP.
What interventions are being tested in trial NCT06056583?
The interventions under investigation include: Cimetidine 200 MG (DRUG).
Who is sponsoring clinical trial NCT06056583?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06056583 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06056583's enrollment target sits among peer trials
50 12th of 16 higher than 4 of 16 other Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postpartum Etonogestrel Implant for Adolescents
COMPLETED · Phase 4
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Excretion of Rivaroxaban in Human Breast Milk
RECRUITING · Phase 1
-
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
RECRUITING · NA
-
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
RECRUITING · NA
-
Orthopaedic Manual Physical Therapy as Part of the Postpartum Care Continuum
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI